Characterisation of human melatonin mt1 and MT2 receptors by CRE-luciferase reporter assay

被引:56
作者
Conway, S
Canning, SJ
Howell, HE
Mowat, ES
Barrett, P
Drew, JE
Delagrange, P
Lesieur, D
Morgan, PJ
机构
[1] Rowett Res Inst, Mol Neuroendocrinol Unit, Aberdeen AB21 9SB, Scotland
[2] Inst Rech Int Servier, F-92415 Courbevoie, France
[3] Lab Chim Pharmaceut, Lille, France
关键词
melatonin receptor; cAMP response element; luciferase; reporter gene assay; HEK293; cell;
D O I
10.1016/S0014-2999(99)00914-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A cyclic AMP response element (CRE)-luciferase reporter gene assay was used to characterise the functional responses of human melatonin mt(1) and human melatonin MT2 receptors, stably expressed in the human embryonic kidney cell line HEK293, to a series of six naphthalenic analogues of melatonin. By comparison to the observed melatonin-mediated inhibition of stimulated luciferase levels the naphthalenic series was identified as comprising agonists, partial agonists and one antagonist of melatonin mt(1) and melatonin MT2 receptor function. Three of the agonist/partial agonist members of this series were also identified as displaying a functional selectivity for the melatonin MT2 receptor. Competitive displacement of 2-[I-125]iodomelatonin binding to the ovine pars tuberalis melatonin ML1 receptor demonstrated a close correlation to the observed functional luciferase responses of the human melatonin mt(1) receptor. We conclude that the CRE-luciferase reporter gene assay provides an effective functional screening method for the pharmacological characterisation of human melatonin receptor subtypes. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:15 / 24
页数:10
相关论文
共 32 条
  • [1] Adam G, 1992, J Pharm Belg, V47, P374
  • [2] Safety of melatonin in long-term use(?)
    Arendt, J
    [J]. JOURNAL OF BIOLOGICAL RHYTHMS, 1997, 12 (06) : 673 - 681
  • [3] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
    ARUNLAKSHANA, O
    SCHILD, HO
    [J]. BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01): : 48 - 58
  • [4] Cloning and functional analysis of a polymorphic variant of the ovine Mel 1a melatonin receptor
    Barrett, P
    Conway, S
    Jockers, R
    Strosberg, AD
    GuardiolaLemaitre, B
    Delagrange, P
    Morgan, PJ
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1997, 1356 (03): : 299 - 307
  • [5] CLONING AND EXPRESSION OF A NEW MEMBER OF THE MELANOCYTE-STIMULATING HORMONE-RECEPTOR FAMILY
    BARRETT, P
    MACDONALD, A
    HELLIWELL, R
    DAVIDSON, G
    MORGAN, P
    [J]. JOURNAL OF MOLECULAR ENDOCRINOLOGY, 1994, 12 (02) : 203 - 213
  • [6] Browning C., 1998, British Journal of Pharmacology, V124, p34P
  • [7] CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
  • [8] Identification of Mel(1a) melatonin receptors in the human embryonic kidney cell line HEK293: Evidence of G protein-coupled melatonin receptors which do not mediate the inhibition of stimulated cyclic AMP levels
    Conway, S
    Drew, JE
    Canning, SJ
    Barrett, P
    Jockers, R
    Strosberg, AD
    GuardiolaLemaitre, B
    Delagrange, P
    Morgan, PJ
    [J]. FEBS LETTERS, 1997, 407 (01) : 121 - 126
  • [9] PHARMACOLOGY AND FUNCTION OF MELATONIN RECEPTORS
    DUBOCOVICH, ML
    [J]. FASEB JOURNAL, 1988, 2 (12) : 2765 - 2773
  • [10] Melatonin receptor antagonists that differentiate between the human Mel(1a), and Mel(1b) recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML(1) presynaptic heteroreceptor
    Dubocovich, ML
    Masana, MI
    Iacob, S
    Sauri, DM
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1997, 355 (03) : 365 - 375